Trials / Unknown
UnknownNCT05174533
Prevalence of Cardiovascular Disorders in Patients Aged 40 and More With Schizophrenia
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Université de Reims Champagne-Ardenne · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
Schizophrenia is a psychiatric disorder, affecting 600,000 patients in France. Patients with schizophrenia have life expectancy decrease from 10 to 20 years because of cardiovascular death. Cardiovascular risk factors are numerous: inadequate diet, smoking, alcohol consumption, diabetes, obesity. Primary prevention of cardiovascular risk in patients suffering from schizophrenia is difficult because of understaff in general practitioners and psychiatrists.
Detailed description
The aim of the study is to describe prevalence of cardiovascular disorders in patients aged 40 and more with schizophrenia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Data collection | electrocardiogram |
Timeline
- Start date
- 2022-01-12
- Primary completion
- 2022-05-12
- Completion
- 2022-07-12
- First posted
- 2021-12-30
- Last updated
- 2022-02-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05174533. Inclusion in this directory is not an endorsement.